Combination of 5-fluorocytosine and amphotericin B in the treatment of chromomycosis

The authors discuss the problem of resistance of chromomycosis to 5-fluorocytosine (5-FC), observed in a previous study in 7 patients initially treated with the drug and subsequently treated with 5-FC associated with other medicaments. All the associations, including that with amphotericin B, failed...

Full description

Saved in:
Bibliographic Details
Published inMedicina cutánea ibero-latino-americana Vol. 7; no. 1-3; p. 1
Main Authors Lopes, C F, Resende, M A, Alvarenga, R J, Moreira, Y K
Format Journal Article
LanguagePortuguese
Published Portugal 1979
Subjects
Online AccessGet full text
ISSN0210-5187

Cover

Abstract The authors discuss the problem of resistance of chromomycosis to 5-fluorocytosine (5-FC), observed in a previous study in 7 patients initially treated with the drug and subsequently treated with 5-FC associated with other medicaments. All the associations, including that with amphotericin B, failed to overcome resistance. Experiments in mice and "in vitro" show a synergism between 5-FC and amphotericin B against "C. albicans", "C. neoformans" and "Fonsecaeae pedrosoi" already confirmed in human subjects infected with the above mentioned fungi. Resistance to 5-FC seems to be irreversible, as shown in previous experiments. The mechanism of action of the drugs on the fungi is discussed, as well as the fact that amphothericin B prevents the development of resistance to 5-FC. Results obtained with the use of the above association in 5 cases of chromomycosis are presented; all the patients had old and well established lesions, and in three cases these lesions were large and disseminated, conditions probably associated with the development of resistance to 5-FC used alone. The drugs were given in small doses, inferior to those usually recommended. The good therapeutic results seem to confirm the synergism observed in laboratory trials. Four cases were discharged as cured and one abandoned treatment for personal reasons. The association seems to act more rapidly than 5-FC alone. Tolerance was excellent in all cases.
AbstractList The authors discuss the problem of resistance of chromomycosis to 5-fluorocytosine (5-FC), observed in a previous study in 7 patients initially treated with the drug and subsequently treated with 5-FC associated with other medicaments. All the associations, including that with amphotericin B, failed to overcome resistance. Experiments in mice and "in vitro" show a synergism between 5-FC and amphotericin B against "C. albicans", "C. neoformans" and "Fonsecaeae pedrosoi" already confirmed in human subjects infected with the above mentioned fungi. Resistance to 5-FC seems to be irreversible, as shown in previous experiments. The mechanism of action of the drugs on the fungi is discussed, as well as the fact that amphothericin B prevents the development of resistance to 5-FC. Results obtained with the use of the above association in 5 cases of chromomycosis are presented; all the patients had old and well established lesions, and in three cases these lesions were large and disseminated, conditions probably associated with the development of resistance to 5-FC used alone. The drugs were given in small doses, inferior to those usually recommended. The good therapeutic results seem to confirm the synergism observed in laboratory trials. Four cases were discharged as cured and one abandoned treatment for personal reasons. The association seems to act more rapidly than 5-FC alone. Tolerance was excellent in all cases.
The authors discuss the problem of resistance of chromomycosis to 5-fluorocytosine (5-FC), observed in a previous study in 7 patients initially treated with the drug and subsequently treated with 5-FC associated with other medicaments. All the associations, including that with amphotericin B, failed to overcome resistance. Experiments in mice and "in vitro" show a synergism between 5-FC and amphotericin B against "C. albicans", "C. neoformans" and "Fonsecaeae pedrosoi" already confirmed in human subjects infected with the above mentioned fungi. Resistance to 5-FC seems to be irreversible, as shown in previous experiments. The mechanism of action of the drugs on the fungi is discussed, as well as the fact that amphothericin B prevents the development of resistance to 5-FC. Results obtained with the use of the above association in 5 cases of chromomycosis are presented; all the patients had old and well established lesions, and in three cases these lesions were large and disseminated, conditions probably associated with the development of resistance to 5-FC used alone. The drugs were given in small doses, inferior to those usually recommended. The good therapeutic results seem to confirm the synergism observed in laboratory trials. Four cases were discharged as cured and one abandoned treatment for personal reasons. The association seems to act more rapidly than 5-FC alone. Tolerance was excellent in all cases.The authors discuss the problem of resistance of chromomycosis to 5-fluorocytosine (5-FC), observed in a previous study in 7 patients initially treated with the drug and subsequently treated with 5-FC associated with other medicaments. All the associations, including that with amphotericin B, failed to overcome resistance. Experiments in mice and "in vitro" show a synergism between 5-FC and amphotericin B against "C. albicans", "C. neoformans" and "Fonsecaeae pedrosoi" already confirmed in human subjects infected with the above mentioned fungi. Resistance to 5-FC seems to be irreversible, as shown in previous experiments. The mechanism of action of the drugs on the fungi is discussed, as well as the fact that amphothericin B prevents the development of resistance to 5-FC. Results obtained with the use of the above association in 5 cases of chromomycosis are presented; all the patients had old and well established lesions, and in three cases these lesions were large and disseminated, conditions probably associated with the development of resistance to 5-FC used alone. The drugs were given in small doses, inferior to those usually recommended. The good therapeutic results seem to confirm the synergism observed in laboratory trials. Four cases were discharged as cured and one abandoned treatment for personal reasons. The association seems to act more rapidly than 5-FC alone. Tolerance was excellent in all cases.
Author Lopes, C F
Alvarenga, R J
Resende, M A
Moreira, Y K
Author_xml – sequence: 1
  givenname: C F
  surname: Lopes
  fullname: Lopes, C F
– sequence: 2
  givenname: M A
  surname: Resende
  fullname: Resende, M A
– sequence: 3
  givenname: R J
  surname: Alvarenga
  fullname: Alvarenga, R J
– sequence: 4
  givenname: Y K
  surname: Moreira
  fullname: Moreira, Y K
BackLink https://www.ncbi.nlm.nih.gov/pubmed/398931$$D View this record in MEDLINE/PubMed
BookMark eNotkDtvwyAYRRnSR5L2H3Rg6mYJgzEwtlZfUqQu3i0CnxUqAy7gwf--qZLl3uWcO9wd2oQYYIO2hNak4rUU92iX8w8hLeOtukO3TEnF6i3qu-iPLujiYsBxxLwapyWmaNYSswuAdbBY-_kUCyRnXMCv-BzlBLgk0MVDKP-eOaXoo1_N2coP6GbUU4bHa-9R__7Wd5_V4fvjq3s5VDOndcUYCNGCbbVoqBgZM1YRzbkFS1kDVBJLuCCSNiCNIUKOepSWHI1kVIm6ZXv0fJmdU_xdIJfBu2xgmnSAuORBNEoJxdkZfLqCy9GDHebkvE7rcDmB_QEDM1mI
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Associação de 5-fluorocitosina e anfotericina B no tratamento da cromomicose
ExternalDocumentID 398931
Genre English Abstract
Journal Article
GroupedDBID 2WC
77H
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CGR
CUY
CVF
DIK
E3Z
EBS
ECM
EIF
EJD
FRP
GROUPED_DOAJ
GX1
NPM
OK1
W2D
Z7D
7X8
ID FETCH-LOGICAL-p521-33e776ed6a7427f33cd90a55ded234e280d0570824e8cc078faf8d0bc83297163
ISSN 0210-5187
IngestDate Fri Jul 11 10:21:39 EDT 2025
Tue Aug 05 11:40:30 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1-3
Language Portuguese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p521-33e776ed6a7427f33cd90a55ded234e280d0570824e8cc078faf8d0bc83297163
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 398931
PQID 74997953
PQPubID 23479
ParticipantIDs proquest_miscellaneous_74997953
pubmed_primary_398931
PublicationCentury 1900
PublicationDate 1979-00-00
19790101
PublicationDateYYYYMMDD 1979-01-01
PublicationDate_xml – year: 1979
  text: 1979-00-00
PublicationDecade 1970
PublicationPlace Portugal
PublicationPlace_xml – name: Portugal
PublicationTitle Medicina cutánea ibero-latino-americana
PublicationTitleAlternate Med Cutan Ibero Lat Am
PublicationYear 1979
SSID ssj0063569
Score 1.2131661
Snippet The authors discuss the problem of resistance of chromomycosis to 5-fluorocytosine (5-FC), observed in a previous study in 7 patients initially treated with...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1
SubjectTerms Adult
Aged
Amphotericin B - administration & dosage
Amphotericin B - pharmacology
Amphotericin B - therapeutic use
Capsules
Chromobacterium - drug effects
Chromoblastomycosis
Cytosine - analogs & derivatives
Drug Evaluation
Drug Therapy, Combination
Flucytosine - administration & dosage
Flucytosine - pharmacology
Flucytosine - therapeutic use
Humans
Injections, Intravenous
Male
Middle Aged
Title Combination of 5-fluorocytosine and amphotericin B in the treatment of chromomycosis
URI https://www.ncbi.nlm.nih.gov/pubmed/398931
https://www.proquest.com/docview/74997953
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS9xAEF9EpPgiai31q-5D344tSXY3e3lU0Yr0-iBXuD4d2S8qaBI0J-hf70w2l0RRaPuyHHuXI8wvmY-d38wQ8lX7KNU6Ecz62DPh0jHTCt7HVKVgnoXxummkPfmZXvwSlzM564cgNtUltf5mnt6sK_kfVGEPcMUq2X9AtvtT2IDPgC-sgDCsf4UxvMwQ2HZOn2T-ZlGCRXqsS6Szh0asAFeJDZnNdTE6WdIae3450sr_ICfv9tHAVfdDb3USEu_5yCzqJqMeF1hYiRwThhy6omR5m_HptPuPsgqaZ0AaRnpfEfr7TvrD0-ObB6xECye7V31-aoLTQpvxR6Pf7SmsDXV6YSBMq7cgimQybu1oq2TV8FlifKAy46EiB_lWtw1aPANPKu6tVMcdDF-A0QXXCjl832cdpwd77TXxzvIO1sla-Pn78UPjR0w3yUYbANDjgOYWWanqbfKhlbT7SKYDUGnp6WtQKYBKh6DSEwoLgEo7UPG6F6DukOn52fT0grWjL1gF_hTj3CmVOpvmSiTKc25sFuVSWmcTLlwyjiz42eC9CTc2Brw8n_uxjbQB_Yw9wfgnslqUhftMaCqklkmkZc4dKGufOSuFyDTWIGuItnfJ0VIyc9AsmC7KC1cu7ucKgmGVSb5LdoLA5lVogDIPMt17Z3-frOMDEc6pDshqfbdwh-C51fpLg9YzFK5Iuw
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Combination+of+5-fluorocytosine+and+amphotericin+B+in+the+treatment+of+chromomycosis&rft.jtitle=Medicina+cut%C3%A1nea+ibero-latino-americana&rft.au=Lopes%2C+C+F&rft.au=Resende%2C+M+A&rft.au=Alvarenga%2C+R+J&rft.au=Moreira%2C+Y+K&rft.date=1979&rft.issn=0210-5187&rft.volume=7&rft.issue=1-3&rft.spage=1&rft_id=info%3Apmid%2F398931&rft.externalDocID=398931
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0210-5187&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0210-5187&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0210-5187&client=summon